Important Safety Information
Prescribing Information
Healthcare Professionals
Contact Us

Important Safety Information
Prescribing Information
Healthcare Professionals
Contact Us

About
ELIGARD
Getting Started
on ELIGARD
- Questions to ask your doctor
- Managing side effects
Treatment
Affordability
Resources
For Care
Partners
Frequently
Asked Questions

About
ELIGARD
Getting Started
on ELIGARD
- Questions to ask your doctor
- Managing side effects
Treatment
Affordability
Resources
For Care
Partners
Frequently
Asked Questions

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Search for:

Search

Recent Posts

Recent Comments

No comments to show.

Archives

No archives to show.

Categories

No categories

Tap for safety information

IMPORTANT SAFETY INFORMATION

ELIGARD^® is used for the treatment of advanced prostate cancer. ELIGARD is a prescription medication that must be administered by a health care professional.

ELIGARD should not be used by anyone who is allergic to any of the ingredients in ELIGARD or to any similar drugs.

ELIGARD causes an increase in testosterone during the first few weeks of therapy and some men may experience new or worsening symptoms of prostate cancer e.g., bone pain, urinary symptoms, or nerve problems such as numbness, during this period. If your cancer has spread to the urinary tract or spine, urinary blockage or pressure on the spine that can lead to paralysis may occur. Your doctor will discuss with you the benefits and risks of taking ELIGARD.

Increased risk of heart attack, sudden death due to heart problems and stroke have also been reported in men taking ELIGARD. ELIGARD may also affect electrical activity in the heart that can cause an irregular heartbeat. Your doctor will monitor you for heart conditions.

Elevated blood sugar and an increased risk of developing diabetes have been reported in men receiving ELIGARD. Your doctor will monitor blood sugar levels.

Convulsions have been observed in patients taking leuprolide acetate, including patients who have a history of seizures, epilepsy, or brain disorders (related to blood vessels, nerves, or tumors), and in those taking medications associated with convulsions. Convulsions have also been reported in patients without any of these conditions.

Rare cases of delayed serious skin reactions occurred in patients receiving leuprolide-containing therapy. Immediately contact your doctor if you develop fever, flu-like symptoms, mucosal lesions, progressive skin rash, or swollen lymph nodes.

ELIGARD may cause fetal harm when administered to a pregnant woman. Expected hormonal changes that occur with ELIGARD treatment increase the risk for pregnancy loss.

ELIGARD may impair fertility in males of reproductive potential.

The most common injection site reactions are transient burning and stinging, pain, bruising, and redness. The most common side effects include hot flashes/sweats, fatigue, weakness, muscle pain, dizziness, clamminess, testicular shrinkage, decreased erections and enlargement of breasts.

Other side effects, including thinning of bones that may lead to fracture, and rare but serious problems with the pituitary gland in the brain, have been reported with ELIGARD.

Call your doctor for medical advice about side effects. You may report side effects to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see full Prescribing Information.

Getting Started on ELIGARD

Treatment Affordability

For Care Partners

Frequently Asked Questions

©2026 Tolmar, Inc. All rights reserved. Tolmar, ELIGARD, TOLMARsync, Tolmar Total Solutions, and their associated logos are trademarks of the Tolmar group. Third-party trademarks, product names, and copyrights belong to their respective owners. TPI.2024.eng.4334.v3 08/26
This site is intended for use by US residents only.

Site Map

Privacy Policy

Tolmar.com

Terms & Conditions

©2026 Tolmar, Inc. All rights reserved. Tolmar, ELIGARD, TOLMARsync, Tolmar Total Solutions,
and their associated logos are trademarks of the Tolmar group. Third-party trademarks, product names, and copyrights belong to their respective owners. TPI.2024.eng.4334.v3 08/26

This site is intended for use by US residents only.

About
ELIGARD
Getting Started
on ELIGARD
- Questions to ask your doctor
- Managing side effects
Treatment
Affordability
Resources
For Care
Partners
Frequently
Asked Questions

Other links

Important Safety Information
Prescribing Information
Healthcare Professionals
Contact Us

You are now leaving ELIGARD.com.

Are you sure you want to leave?

You are now navigating to the healthcare provider site.

Are you a healthcare provider?

Skip to content